Inhibition of angiotensin II type 1 receptor reduces oxidative stress damage to the intestinal barrier in severe acute pancreatitis
- PMID: 37132556
- PMCID: PMC11895966
- DOI: 10.1002/kjm2.12692
Inhibition of angiotensin II type 1 receptor reduces oxidative stress damage to the intestinal barrier in severe acute pancreatitis
Abstract
Intestinal barrier injury is a common complication of severe acute pancreatitis (SAP), which is often accompanied by intestinal mucosal barrier injury and results in serious consequences. However, the exact mechanism remains unclear. We aimed to investigate whether angiotensin II type 1 receptor (AT1)-mediated oxidative stress is involved in SAP intestinal barrier injury and assessed the effects of inhibiting this pathway. The SAP model was established by retrograde bile duct injection of sodium taurocholate (5%). The rats were divided into three groups: the control group (SO), the SAP group (SAP), and the azilsartan intervention group (SAP + AZL). Serum amylase, lipase, and other indexes were measured to evaluate SAP severity in each group. Histopathological changes in the pancreas and intestine were evaluated by HE staining. The oxidative stress of intestinal epithelial cells was detected by superoxide dismutase and glutathione. We also detected the expression and distribution of intestinal barrier-related proteins. The results showed that the serum indexes, the severity of tissue damage, and the level of oxidative stress in the SAP + AZL group were significantly lower than in the SAP group. Our study provided hitherto undocumented evidence of AT1 expression in the intestinal mucosa, confirming that AT1-mediated oxidative stress is involved in SAP intestinal mucosal injury, and inhibiting this pathway could effectively reduce intestinal mucosal oxidative stress injury, providing a new and effective target for the treatment of SAP intestinal barrier injury.
Keywords: AT1; intestinal mucosal barrier; oxidative stress; severe acute pancreatitis.
© 2023 The Authors. The Kaohsiung Journal of Medical Sciences published by John Wiley & Sons Australia, Ltd on behalf of Kaohsiung Medical University.
Conflict of interest statement
All authors declare no conflict of interest.
Figures






Similar articles
-
Severity of pancreatitis‑associated intestinal mucosal barrier injury is reduced following treatment with the NADPH oxidase inhibitor apocynin.Mol Med Rep. 2016 Oct;14(4):3525-34. doi: 10.3892/mmr.2016.5678. Epub 2016 Aug 26. Mol Med Rep. 2016. PMID: 27573037 Free PMC article.
-
High-Fat Diet Aggravates the Intestinal Barrier Injury via TLR4-RIP3 Pathway in a Rat Model of Severe Acute Pancreatitis.Mediators Inflamm. 2019 Dec 17;2019:2512687. doi: 10.1155/2019/2512687. eCollection 2019. Mediators Inflamm. 2019. PMID: 31933540 Free PMC article.
-
Elevation of HO-1 expression protects the intestinal mucosal barrier in severe acute pancreatitis via inhibition of the MLCK/p-MLC signaling pathway.Exp Cell Res. 2023 Mar 15;424(2):113508. doi: 10.1016/j.yexcr.2023.113508. Epub 2023 Feb 9. Exp Cell Res. 2023. PMID: 36764591
-
Therapeutic effect of Qingyi decoction in severe acute pancreatitis-induced intestinal barrier injury.World J Gastroenterol. 2015 Mar 28;21(12):3537-46. doi: 10.3748/wjg.v21.i12.3537. World J Gastroenterol. 2015. PMID: 25834318 Free PMC article.
-
Captopril pretreatment protects the lung against severe acute pancreatitis induced injury via inhibiting angiotensin II production and suppressing Rho/ROCK pathway.Kaohsiung J Med Sci. 2016 Sep;32(9):439-45. doi: 10.1016/j.kjms.2016.07.008. Epub 2016 Aug 24. Kaohsiung J Med Sci. 2016. PMID: 27638402 Free PMC article.
Cited by
-
Ulinastatin inhibits macrophage M1 polarization to improve acute pancreatitis-associated intestinal barrier dysfunction by promoting Nrf2 signaling pathway activation.Eur J Med Res. 2025 Jul 26;30(1):676. doi: 10.1186/s40001-025-02952-2. Eur J Med Res. 2025. PMID: 40713698 Free PMC article.
References
-
- Petrov MS, Shanbhag S, Chakraborty M, Phillips AR, Windsor JA. Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis. Gastroenterology. 2010;139(3):813–20. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous